Clinical Trial Update: Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer [NA]

View source ↗

Summary

This clinical trial update describes a study using circulating tumor DNA detection to predict residual disease after potentiated radiotherapy in locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Centre Jean Perrin | Conditions: Locally Advanced Head and Neck Carcinoma | NA | Status: RECRUITING